Viewing StudyNCT00112229



Ignite Creation Date: 2024-05-05 @ 11:43 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00112229
Status: COMPLETED
Last Update Posted: 2013-04-22
First Post: 2005-05-31

Brief Title: Immunotherapy of HLA-A2 Positive Stage IIIIV Melanoma Patients
Sponsor: Centre Hospitalier Universitaire Vaudois
Organization: Centre Hospitalier Universitaire Vaudois

Conditions & Keywords Data

Conditions:
Name
Melanoma
Keywords:
Name View
Montanide View
Immunotherapy View
Vaccination View
Melanoma View
Melan-AMart-1 peptide View
Tyrosinase peptide View
CpG View